{"name":"CSPC Pharmaceutical Group","slug":"cspc-pharma","ticker":"1093.HK","exchange":"HKEX","domain":"cspc.com.hk","description":"CSPC Pharmaceutical Group researches, develops, manufactures and sells pharmaceutical products. Its headquarters is in China's Hebei Province.","hq":"Shijiazhuang, Hebei, China","founded":2000,"employees":"19700","ceo":"Cai Dongchen (Chairman & CEO)","sector":"Neurology / Oncology / Generics","stockPrice":7.96,"stockChange":-0.09,"stockChangePercent":-1.12,"marketCap":"$13.4B","metrics":{"revenue":3832807235.6467505,"revenueGrowth":-3.3,"grossMargin":65.6,"rdSpend":0,"netIncome":572151934.2225101,"cash":1528772565.4786048,"dividendYield":3.73,"peRatio":20.4,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Lansoprazole patent cliff ($1.2B at risk)","drug":"Lansoprazole","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-01","label":"Omeprazole patent cliff ($800M at risk)","drug":"Omeprazole","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-28","type":"earnings","headline":"CSPC Pharmaceutical Group Reports 2023 Annual Results","summary":"CSPC Pharmaceutical Group announced its 2023 annual results, with revenue reaching RMB 23.6 billion and net profit attributable to shareholders of RMB 4.3 billion.","drugName":"","sentiment":"positive"},{"date":"2023-12-01","type":"deal","headline":"CSPC Pharmaceutical Group Partners with US-based Biotech Company","summary":"CSPC Pharmaceutical Group announced a partnership with a US-based biotech company to co-develop a new cancer treatment.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"regulatory","headline":"CSPC Pharmaceutical Group Receives Approval for New Generic Drug","summary":"CSPC Pharmaceutical Group received approval from the Chinese FDA for a new generic drug, expanding its portfolio of affordable medicines.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-wFBVV95cUxNRjlMdXBrbXhRcjJIakMzRlpNcVh6NkFna3R5ZmNWbHI4eUVZVGZabXpTQWxIRGRJVzdiandyc21rdi1wejVzWUNaTlQxSmZlaVRQb2ttWVNLTlBMbWN4NGZvb1VTZ2NXWlF3bktVd2tUNElSdHdveXRNMVd6WDBfU3pYSmZsUTFMZUUxMnNxUEpfZDNUcUxNRTN0NVdhVklsLWhsOG82ZkVwM1F2TjJXVUs0Wk1CX0FucGNHbFRrcEV3Y04ySWl4YXdnMlBGQ21vcW1Lemh6VDBmSWpuQzhCUjhidXJQY3BIT0JFblRPZ3RLZ1pZU0YzVXUwWdIB-wFBVV95cUxNRjlMdXBrbXhRcjJIakMzRlpNcVh6NkFna3R5ZmNWbHI4eUVZVGZabXpTQWxIRGRJVzdiandyc21rdi1wejVzWUNaTlQxSmZlaVRQb2ttWVNLTlBMbWN4NGZvb1VTZ2NXWlF3bktVd2tUNElSdHdveXRNMVd6WDBfU3pYSmZsUTFMZUUxMnNxUEpfZDNUcUxNRTN0NVdhVklsLWhsOG82ZkVwM1F2TjJXVUs0Wk1CX0FucGNHbFRrcEV3Y04ySWl4YXdnMlBGQ21vcW1Lemh6VDBmSWpuQzhCUjhidXJQY3BIT0JFblRPZ3RLZ1pZU0YzVXUwWQ?oc=5","date":"2026-04-06","type":"regulatory","source":"simplywall.st","summary":"CSPC Pharmaceutical Group (SEHK:1093) Valuation Check After Aprepitant Injection Approval - simplywall.st","headline":"CSPC Pharmaceutical Group (SEHK:1093) Valuation Check After Aprepitant Injection Approval","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2026-03-26","type":"pipeline","source":"simplywall.st","summary":"CSPC Pharmaceutical Group (SEHK:1093) Margin Stability At 14.9% Tests Bullish Growth Narratives - simplywall.st","headline":"CSPC Pharmaceutical Group (SEHK:1093) Margin Stability At 14.9% Tests Bullish Growth Narratives","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxNVFZfRnhhSUprYUtHanJWR0pjUWNRMGNQNnJhNWxPVjRtLVQ4VFZ6WG1ENGZqNkpuUW9nS1RjMnJkSVB3S2ZEbnZxdDJYV2VPUkY4NlNqRDctQkI4RzJud1VYUVQ5NUpKazhmME9ZT0dtdlNMMGRrY0RGZkZuSjJZTWg5blE3TEg5ajFwZFFwaw?oc=5","date":"2026-02-12","type":"deal","source":"thebambooworks.com","summary":"Big deal, bigger doubts: CSPC slides after $18.5 billion pact - thebambooworks.com","headline":"Big deal, bigger doubts: CSPC slides after $18.5 billion pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNbUZLQTktLTU5NnY5RWFBSFQyd3diSkt2aXJheC01T1NmWlRlRmRmNV9PNWZyX3dVejJaVDFtSlA2QThaa09hSVU5X3R5bzA5V2ttdkFfR1YzWjlCY21TaXA2WHcyaGk2QUE2VnFCcm1xUlU3V25tTkFHQzM0MGxTbDc4bnl0VkJNZ1ZDbUFiMmVva0xDQzlDUXBZeUQ0SlJ5MnVYX0N3?oc=5","date":"2026-01-31","type":"pipeline","source":"Meyka","summary":"1093.HK CSPC Pharma (HKSE) down 9.00% pre-market 31 Jan 2026: AstraZeneca impact - Meyka","headline":"1093.HK CSPC Pharma (HKSE) down 9.00% pre-market 31 Jan 2026: AstraZeneca impact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNZ3Nib1dEdThpN1hJcFdYdGRKbW5hYnIyQlM2MXJkVnNMVlRGYUhnMUtGUlB1U2c2SFZibUFzbGozc1B5YXVkeWg2UC16NFZLeTlMZW01aFZWdlBMcVJNakZMS193RUdPRGszRVdGNWRTLW04S214MWpibGJwVjdGbXJzbUQ3TUkwUFJuWG1CelRIQUh6TFNjY21UT2x4T3Z1T2dyNzBibUJjbnV2Wkx6M3dKN1FKTm54VVExWWtmaw?oc=5","date":"2026-01-18","type":"pipeline","source":"AD HOC NEWS","summary":"CSPC Pharmaceutical Group Ltd Is Quietly Pumping – But Is This Sleeper Stock Worth Your Money? - AD HOC NEWS","headline":"CSPC Pharmaceutical Group Ltd Is Quietly Pumping – But Is This Sleeper Stock Worth Your Money?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-13","type":"pipeline","source":"simplywall.st","summary":"After Leaping 28% CSPC Pharmaceutical Group Limited (HKG:1093) Shares Are Not Flying Under The Radar - simplywall.st","headline":"After Leaping 28% CSPC Pharmaceutical Group Limited (HKG:1093) Shares Are Not Flying Under The Radar","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNVVk5NWlfT3ZScThhMWFvdXNHMFpkX0ljSUdMR0t4VmVDR0U2czlqUDBQck1tQzVvUkV4X3dsUThsQ0ZYbzFfdW05ZHcyZ0VLcWFzWlBFVm1jeTFxaHNhNXlzVU9Kb3lXOHdjaEgyR3BmM21NNHVGaEdKM1NaQTAtMHBWSzd5YkNEbWV0eHJkeHJnTGVLSldr?oc=5","date":"2025-03-06","type":"earnings","source":"thebambooworks.com","summary":"Earnings blow for CSPC Pharma as the state drives a hard bargain - thebambooworks.com","headline":"Earnings blow for CSPC Pharma as the state drives a hard bargain","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNRFc0WVd3TnY0RXFjQmEzWnNOejNWOXV5MXVIYTdRc0NuS1R3ZHItVlAwYmR2UmhWcnB6RTZ5aVNPa0d2bk8yZ2lOWUdZMGNyU2tmMHVkWTVVc1Rvcm8yWnpPOWlQa1lwNldnNE5SbHV3T0s5WUxJc0owWHBBX0l1OHF0Q2FhOHpxTVlxZndVdVVuRDA?oc=5","date":"2024-09-19","type":"pipeline","source":"thebambooworks.com","summary":"CSPC Pharma taps R&D superstar in quest for new breakout drugs - thebambooworks.com","headline":"CSPC Pharma taps R&D superstar in quest for new breakout drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOTWNWRjlMUHNNOVA0djZjWjhlQUFRSE1kOUZJWFk1UmlSdWRLY0dTb1ZVdXBBUXhVZ0JkX2F4OXZjcVhuazFnVkxGMmRzZXg2MVN6NkIzYS16dS1IdnU3c1B6dlA3UWp5RlBkMHRKa1JzVFZsWjJCNVBCRWxobzQ3aWVXS1pBSUtKTXpLYTJ5bGNZa2R1VmZab9IBngFBVV95cUxPUV9ZcHRrN1daYXF2S05UOXJkZmFQUEZjVWFXMW9zeWg2aXJGZ0EydTFSMDAyYUltbVM2ejNWQWhwaEF4WkVMM1NVRm50dTZmNjd3RHhZR3prRzd6Y2tlNFl4OEd3TWJ1Y3FKRGhkUzVLUnJjeE9odk9hRTVJVXRNLW5Sd085Ym1xcDRRckxXZThaamJLUmpaaVZkSkVWQQ?oc=5","date":"2023-10-27","type":"pipeline","source":"Dhaka Tribune","summary":"CSPC Pharma (HKG: 1093) up 11.5% - testing permission for the cancer drug - Dhaka Tribune","headline":"CSPC Pharma (HKG: 1093) up 11.5% - testing permission for the cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPQm9sbEVFV3VIbHhNMlB5OVg5QU10V2t3ZTlHem1PN2o5NTVEd0lWNlhOeEFZU2tlLVdBaklyNmJnOXpxU2Y1V0ZpLTVQRnBGUHhuQUIyRG1oUE41b3laYzloclNaXzEtaXU2S3dqeTROWlpuYUJ0MWlDVXhxMHRXMER0cmpGNHdpR1JvTzJ0VzVfS1VoaTI5RjR3?oc=5","date":"2023-03-29","type":"pipeline","source":"thebambooworks.com","summary":"CSPC Pharma wins China’s mRNA vaccine race, but just not fast enough - thebambooworks.com","headline":"CSPC Pharma wins China’s mRNA vaccine race, but just not fast enough","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQZ0MwOWN3UG5XaXg2WnNsYUxfWkpPeW9Tc2NhUHVnYnpiZjFSWDMwOFdRWVdrQkNOemJ6R1FTaDVGQXBIMnNzcElDaUlpVlpHZHphVTlkQnQ2a0xTOEVLVzJ1TlpHMXZxcjdlNzRRS3hDN2U3LXk2M0FHWFJ3SXNnZWZSWVJ0dW5yMkZYMlRVdHZWWXdiQXNXVklVV3cxUQ?oc=5","date":"2017-11-28","type":"pipeline","source":"hkex.com.hk","summary":"CSPC PHARMACEUTICAL GROUP LTD. (1093) - hkex.com.hk","headline":"CSPC PHARMACEUTICAL GROUP LTD. (1093)","sentiment":"neutral"}],"patents":[{"drugName":"Lansoprazole","drugSlug":"lansoprazole","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1200000000},{"drugName":"Omeprazole","drugSlug":"omeprazole","patentNumber":"","type":"Patent Cliff","expiryDate":"2026-06-01","territory":"US","annualRevenue":800000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sino Biopharmaceutical","Hengrui Pharmaceutical","Jiangsu Hengrui Medicine"],"therapeuticFocus":["Neurology","Oncology","Generics"],"financials":{"source":"yahoo_finance","revenue":3832807362.9846,"revenuePeriod":"2025-12-31","revenueHistory":[{"period":"2025-12-31","value":3832807362.9846},{"period":"2024-12-31","value":4275435200.89958},{"period":"2023-12-31","value":4635172731.11293},{"period":"2022-12-31","value":4559535669.84008}],"grossProfit":2514112365.69031,"grossProfitHistory":[{"period":"2025-12-31","value":2514112365.69031},{"period":"2024-12-31","value":2991659955.89847},{"period":"2023-12-31","value":3268439235.41422},{"period":"2022-12-31","value":3280189689.17278}],"rdSpend":856102824.81511,"rdSpendHistory":[{"period":"2025-12-31","value":856102824.81511},{"period":"2024-12-31","value":765008068.74112},{"period":"2023-12-31","value":711909217.26375},{"period":"2022-12-31","value":587539784.21332}],"sgaSpend":1074226075.83387,"operatingIncome":616247394.901,"operatingIncomeHistory":[{"period":"2025-12-31","value":616247394.901},{"period":"2024-12-31","value":807447828.46678},{"period":"2023-12-31","value":1034032119.51947},{"period":"2022-12-31","value":996246676.09041}],"netIncome":572151948.37116,"netIncomeHistory":[{"period":"2025-12-31","value":572151948.37116},{"period":"2024-12-31","value":637873458.92195},{"period":"2023-12-31","value":865621034.28525},{"period":"2022-12-31","value":897759839.9603}],"eps":0.3398,"epsHistory":[{"period":"2025-12-31","value":0.3398},{"period":"2024-12-31","value":0.3687},{"period":"2023-12-31","value":0.4947},{"period":"2022-12-31","value":0.5111}],"cash":897490868.23005,"cashHistory":[{"period":"2025-12-31","value":897490868.23005},{"period":"2024-12-31","value":998835584.2622299},{"period":"2023-12-31","value":1770824832.68471},{"period":"2022-12-31","value":1517738499.13239}],"totalAssets":6882421220.62778,"totalLiabilities":1790363823.46069,"totalDebt":94487779.18293,"equity":4889856977.81559,"operatingCashflow":859477572.5845699,"operatingCashflowHistory":[{"period":"2025-12-31","value":859477572.5845699},{"period":"2024-12-31","value":668326806.67528},{"period":"2023-12-31","value":615881151.2025499},{"period":"2022-12-31","value":1124090192.22328}],"capex":-336103094.81261,"capexHistory":[{"period":"2025-12-31","value":-336103094.81261},{"period":"2024-12-31","value":-394817486.49052},{"period":"2023-12-31","value":-279003565.18859},{"period":"2022-12-31","value":-401275166.12483996}],"freeCashflow":523374477.77195996,"dividendsPaid":-368061947.34648997,"buybacks":-40918042.95041,"employees":19700,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":null,"ebitda":null,"period":"2025-03-31","revenue":null,"epsBasic":0.1291,"netIncome":null,"rdExpense":null,"epsDiluted":0.1291,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":7.96,"previousClose":8.05,"fiftyTwoWeekHigh":11.63,"fiftyTwoWeekLow":5.67,"fiftyTwoWeekRange":"5.67 - 11.63","fiftyDayAverage":8.9,"twoHundredDayAverage":9.14,"beta":0.8,"enterpriseValue":12319778075.663565,"forwardPE":12.5,"priceToBook":2.39,"priceToSales":3.49,"enterpriseToRevenue":3.21,"enterpriseToEbitda":16.36,"pegRatio":1.16,"ebitda":753184928.6517043,"ebitdaMargin":19.7,"freeCashflow":431307029.13421565,"operatingCashflow":859477585.5541657,"totalDebt":94487778.00387584,"debtToEquity":1.9,"currentRatio":2.19,"returnOnAssets":5.4,"returnOnEquity":11.3,"analystRating":"2.0 - Buy","recommendationKey":"buy","numberOfAnalysts":23,"targetMeanPrice":11.6,"targetHighPrice":19.36,"targetLowPrice":6.6,"dividendRate":0.3,"payoutRatio":0.65,"fiveYearAvgDividendYield":3.22,"exDividendDate":1782259200,"insiderHeldPercent":31.9,"institutionHeldPercent":34.7,"sharesOutstanding":11405451732,"floatShares":7716208819,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":0.39,"epsForward":0.63,"revenuePerShare":2.28,"bookValue":3.33,"officers":[{"age":71,"name":"Mr. Dongchen  Cai","title":"Executive Chairman"},{"age":45,"name":"Dr. Lei  Cai","title":"CEO & Vice Chairman of the Board"},{"age":55,"name":"Mr. Qingjie  Wei","title":"COO & Vice-Chairman of the Board"},{"age":49,"name":"Dr. Chunlei  Li","title":"Executive Director & Chief Scientist"},{"age":62,"name":"Mr. Huaiyu  Wang","title":"Executive Director"},{"age":55,"name":"Mr. Zhenguo  Wang","title":"Executive Director"},{"age":56,"name":"Mr. Cuilong  Zhang","title":"Executive Director"},{"age":48,"name":"Dr. Bing  Yao","title":"Executive Director"}],"industry":"Drug Manufacturers - General","irWebsite":"http://www.cpg.hk/eng/sharewholder_e.htm","website":"https://www.cspc.com.hk","phone":"86 311 8703 7015"}}